Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years
Pharmaceutical Technology
JUNE 29, 2022
Research and drug development for rare diseases has shifted from “niche” to conventional, aided by multiple drivers of growth in the field and favorable legislation. An orphan drug designation does not automatically translate into approval. What happens after a drug gets an orphan drug designation?
Let's personalize your content